Explainer-How the Merck/Moderna Cancer Vaccine Works and Possible Barriers to Wide Use
Interim trial data showed the vaccine-Keytruda combination cut melanoma recurrence and spread, while more studies are underway in several other cancers.
8 Articles
8 Articles
What does Moderna's melanoma treatment mean for cancer research? We asked 2 local experts
Moderna's stock price soared last week after the release of promising news about an experimental melanoma treatment using an mRNA-based cancer vaccine that the Cambridge company is working on with Merck. Two local cancer researchers explain how the treatment works and how it could mean for their field.
Clinical Vaccine Trial Shows Hope for Skin Cancer Patients
Photo: Kevin Whitlock ~ USA TODAY NETWORK PODCAST: August 25, 2026 ~ Chris Renwick and Lloyd Jackson check in with Dr. Yusra Shao, medical oncologist at Karmanos Cancer Center, about a new vaccine to prevent melanoma. How does it work, and how soon will this become widely available?WASHINGTON D.C. ~ Medical companies Moderna and Merck announced last week that a new mRNA-based vaccine for cancer has shown promise in clinical trials, givi…
A personalized cancer vaccine developed by Moderna and Merck showed promising results by reducing the risk of recurrence of melanoma.
A cancer vaccine seems to be closer than ever
Scientists are on the cusp of fulfilling a decades-long quest: to use vaccines to teach the immune system to spot and destroy cancer cells. News that an mRNA cancer vaccine developed by Merck & Co. and Moderna Inc. kept melanoma from returning in a large, late-stage trial marks a critical next chapter for a technology beleaguered by post-pandemic political backlash and years of false starts before then, according to the Tribune News Service. The…
Coverage Details
Bias Distribution
- 80% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium










